Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01777, or long intergenic non-protein coding RNA 1777, is an autonomously transcribed RNA locus classified as a lincRNA. LincRNAs are non-protein coding transcripts greater than 200 nucleotides that do not overlap annotated protein-coding genes. These RNAs often act in cis or trans to regulate gene expression, modulate chromatin architecture, stabilize RNA, and fine-tune nearby gene expression. LINC01777 is annotated in the human genome, but its specific molecular function and disease association have not been characterized. LincRNAs as a class display diverse regulatory activities, often exerting tissue-specific or developmental-stage-specific effects, but only a minority have well-defined molecular or disease roles at present[1][3][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1777 (LINC01777).